Biotech Stocks Crispr, Editas, Intellia Fall On Gene-Editing Study

Shares in biotech stocks Crispr Therapeutics (CRSP), Editas Medicine (EDIT) and Intellia Therapeutics (NTLA) crashed Monday after a scientific publication said the companies' gene-editing techniques might cause cancer.

X

Crispr plummeted 12.4% to 59.67 in midday trading on the stock market today. Editas tumbled 7.5% to 36.25 while Intellia sank 7.7% to 25.12.

Nature Medicine published a study on the CRISPR/Cas9 gene-editing platform, designed to help treat serious diseases. The Swedish...

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Crispr Therapeutics [+]    CRSP [+]    Editas Medicine [+]    Intellia Therapeutics [+]    NTLA [+]    Monday [+]    Crispr [+]    Editas [+]    Intellia [+]    Nature Medicine [+]    CRISPR [+]    Swedish [+]   

More #news: